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ABSTRACT   
The induced expression of nitric oxide synthase (iNOS) controls the intracellular growth of 
Leishmania in infected macrophages. Histones deacetylases (HDACs) negatively regulate gene 
expression through the formation of complexes containing transcription factors such as NF-B 
p50/50. Herein, we demonstrated the occupancy of p50/p50_HDAC1 to iNOS promoter associated 
with reduced levels of H3K9Ac. Remarkably, we found increased levels of HDAC1 in L. amazonensis-
infected macrophages. HDAC1 upregulation was not found in L. major-infected macrophages. The 
parasite intracellular load was reduced in HDAC1 knocked-down macrophages, which presented 
increased nitric oxide levels. HDAC1 silencing led to the occupancy of CBP/p300 to iNOS promoter 
and the rise of H3K9Ac modification. Importantly, the immunostaining of skin samples from 
hiporeactive cutaneous leishmaniasis patients infected with L. amazonensis, revealed high levels of 
HDAC1. In brief, L. amazonensis induces HDAC1 in infected macrophages, which contribute to 
parasite survival and is associated to hiporeactive stage found in L. amazonensis infected patients. 
 
INTRODUCTION 
Leishmaniasis is an emerging parasitic disease caused by several species of Leishmania and 
affects ~12 million people worldwide with approximately 2 million new infections per year [1]. 
Depending on the species and the host immune response, diverse clinical manifestations can be 
observed [2]. 
Leishmania amazonensis is endemic in Brazil and is the causative agent of local cutaneous 
leishmaniasis (LCL) and a more severe form, the anergic diffuse cutaneous leishmaniasis (ADCL). The 
immunological response is associated to a T-cell hyposensitivity pole and patients present a 
nonreactive profile characterized by negative delayed type hypersensitivity (DTH) reaction to 
Leishmania skin test, as well as a marked Th2-type immune response [3, 4, 5]. In vitro infections 
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corroborate the in vivo immune repressive scenario, which is characterized by the suppression of the 
inherent initial response, noted by the inhibition of pro-inflammatory molecules such as IL12, IFN, 
TNF, IL1 [6, 7]. 
The production of Nitric Oxid (NO) by iNOS is crucial to control Leishmania parasites at all 
stages of infection [8]. In murine cutaneous leishmaniasis, iNOS was shown to be indispensable for 
the cell innate response to L. major and for the resolution of skin lesions [9]. Patients with visceral 
leishmaniasis caused by L. chagasi also expressed iNOS at higher levels in bone marrow [10].  L. 
amazonensis activates the NF-B transcriptional repressor homodimer (p50/p50), which binds to 
iNOS promoter and determines its transcriptional repression. This regulation seems to be species-
specific since L. major activates a different NF-B complex, which in fact supports iNOS expression 
when activated [11]. 
 Covalent post-translational modifications of histones such as acetylation and phoshorylation 
control gene expression in eukaryotes. The acetylation of histones allows the remodeling of the 
chromatin in order to expose regulatory DNA sequences to transcriptional regulators. Two classes of 
enzymes, histone acetyltransferases (HATs) and HDACs are responsible to maintain the acetylation 
status of histones [12, 13]. Different NF-B complexes have been demonstrated to recruit and 
interact with specific members of HDAC family [14, 15]. In particular, p50 NF-B subunit interacts 
with HDAC1 protein forming a complex described as repressome and induces the transcriptional 
downregulation of several NF-B-dependent genes [16, 17, 18].  
Here, we report for the first time that L. amazonensis induces the upregulation of HDAC1 
expression in infected macrophages both in vitro and in human clinical samples. HDAC1 in turns is 
effectively recruited by p50/p50 NF-B complex to iNOS promoter leading to the deacetylation of 
histone H3K9 and the downregulation of iNOS gene and consequent NO levels. Altogether, these 
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events contribute for parasite survival and progression of the infection and highlight the importance 
of epigenetic modifications induced by the parasite to effectively manipulate the cell host response.   
 
RESULTS 
HDAC1 binds to p50/p50 NF-B forming a repressor complex in iNOS promoter during L. 
amazonensis infection 
L. amazonensis infection leads to NF-B p50/50 activation throughout PI3K/Akt pathway 
[19] and this homodimer is responsible for the host iNOS downregulation during the infection. 
Several reports have demonstrated the role of HDAC1 in the formation of chromatin repressome 
complexes. Moreover, HDAC1 binds to NF-B p50/p50 homodimer in several promoters leading to 
transcriptional repression [16, 17, 18].   
To address the hypothesis that HDAC1 was recruited to the iNOS promoter, we have carried 
out ChIP assays of infected macrophages. Our data show an increased occupancy of HDAC1 to NF-B 
binding sites of iNOS promoter (Figure 1A). Importantly, HDAC1 induction seems to be L. 
amazonensis specific, since no changes in HDAC1 levels were observed in L. major infection (Figure 
1B). Re-ChIP analysis confirmed that HDAC1 and p50/p50 NF-B integrate the same repressor 
complex in the iNOS promoter during L. amazonenis infection (Figure 1C).  
The levels of macrophage infection are depicted in supplementary figure 1 A and B. It has 
been demonstrated that GP63 from several Leishmania species may alter the macrophage nuclear 
envelope nuclear affecting the translocation of the transcription factors NF-κB and AP-1 [20] (Isnard 
et al., 2015). To verify the efficiency of extraction and eliminate artefactual CHIP differences, the 
nuclear levels of H3 were evaluated during the infection. There were no differences in nuclear 
histone H3 levels in our assays (supplementary figure 1C).   
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Corroborating the enrichment of HDAC1 at iNOS promoter, we observed decreased levels of 
acetylated histone 3 (Lys 9), an epigenetic marker associated with transcriptional activation (Figure 
1D). Chromatin immunoprecipitation of histone H3 was carried out in the normalization of H3K9Ac 
(supplementary figure 1D).   
 
L. amazonenis induces macrophage HDAC1 expression  
The CHIP-HDAC1 results prompted us to investigate whether L. amazonensis would induce 
the cellular levels of HDAC1 in macrophages. By western blot we observed an increase of both 
nuclear and total HDAC1 protein levels in early times of infection (Figure 2A and 2B respectively). 
Thus, the expression of HDAC1 increases during infection and it seems to be L. amazonensis specific, 
since no changes were observed in HDAC1 expression due to L. major infection (Figure 2D).  
The overall histone deacetylase activity was also measured during macrophage infection 
(Figure 2C). We can observe a slight, but significative increase of total deacetylase activity in 5 h 
infection, probably due to the raise of HDAC1 expression. During 18 h of infection, the HDAC activity 
was not altered corroborating the unaltered HDAC1 nuclear levels verified in 18 h of infection 
(supplementary figure 2). 
 
L. amazonensis infection promotes Sp1 binding to HDAC1 promoter 
We have carried out qPCR assays in infected macrophages to analyze the HDAC1 RNA levels. 
Figure 3A shows the increase of HDAC1 mRNA levels in 4 hours of infection (Figure 3A). Then, we 
decided to test the activity of the HDAC1 promoter during the infection. The Luciferase gene 
reporter assay revealed the upregulation of HDAC1 promoter (Figure 3B), suggesting its induction by 
transcription factors. 
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The human HDAC1 promoter displays several putative transcriptional factors binding sites 
including Sp1, Sp3, AP1, C/EBP and AP2 [21]. Since L. amazonesis induces Sp1 activation [22], we 
addressed the question whether this parasite upregulates HDAC1 promoter via this transcriptional 
factor. Accordingly, we observed by ChIP assays, that L. amazonensis induces Sp1 occupancy in 
HDAC1 promoter suggesting its participation in the activation of the cognate promoter (Figure 3C). 
We also investigated the contribution of AP1 on HDAC1 expression during L. amazonensis infection. 
We verified the effect of the specific AP-1 inhibitor, SR 11302, on the HDAC1 expression in our 
model. Figure 5D and 5E show the inhibition of HDAC1 expression when infected macrophages were 
pretreated with the AP1 inhibitor. These results strongly suggest that AP1 plays a role in HDAC1 
expression.  
 
HDAC1 knocking down correlates with increased NO production and reduced parasite load 
Since we have observed increased levels of nuclear HDAC1 and the enrichment of HDAC1 in 
NF-B binding sites of iNOS promoter during the infection, we decided to verify the role of this 
enzyme in iNOS repression. To address this question, we successfully silenced HDAC1 in THP-1 cells 
throughout shRNA lentivirus transduction using three shHDAC1 different constructions (Figure 4A). 
The construction shHDAC1 (3) was selected to proceed with the subsequent experiments. 
To verify the role of HDAC1 in the course of the infection, HDAC1 knocked-down THP1 cells 
were infected with L. amazonensis for 4 h to evaluate the parasite uptake and for 48 h to analyze the 
survival of the parasites. It can be observed that there is no alteration in the uptake of the 
Leishmania (figure 4B). However, HDAC1 silencing impaired the parasite load compared to 
scrambled control (Figure 4C) probably due to the high production of nitric oxide in HDAC1 knocked-
down cells (Figure 4D). The supplementary Figure 3 shows no alteration in cell viability during the 
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infection of shScr and shHDAC1 cells. These experiments corroborate the role of HDAC1 in iNOS 
donwregulation and its importance in the progression of the infection. 
 
HDAC1 regulates the occupancy of CBP-300 and H3K9Ac levels at iNOS promoter during L. 
amazonensis infection 
Further, we aimed to characterize the occupancy by the CBP-300 (a Histone Acetylase 
Enzyme) suffered by the iNOS promoter and the associated levels of H3K9Ac residues in HDAC1 
knocked-down THP1cells. Figure 5A shows the increased occupancy of CBP/p300 to the iNOS 
promoter during the infection. Accordingly, it was observed that H3K9Ac levels were increased in L. 
amazonensis infected HDAC1 knocked-down macrophages (Figure 4B). Chromatin 
immunoprecipitation of histone H3 was used in the normalization of H3K9Ac ChIP results 
(supplementary Figure 4).  These data corroborate the notion that HDAC1 plays a pivotal role in iNOS 
downregulation due to L. amazonensis infection by preventing the histone acetyltransferase 
(CBP/p300) binding to iNOS promoter and further acetylation of H3K9 residue. 
 
Cutaneous lesions of patients infected with L. (L.) amazonensis DTH- exhibit high levels of HDAC1 
expression 
 We aimed to compare the HDAC1 expression in two distinct clinical and immunopathological 
spectrum of cutaneous leishmaniasis caused by L. (Leishmania) amazonensis and L. (Vianna) 
braziliensis. L. amazonensis infections are characterized by a hyposensitivity polo DTH- and it is 
implicated with ADCL while L. braziliensis infections present a hypersensitivity polo DTH+ and may 
cause mucocutaneous leishmaniasis (MCL). Moreover, both species can also induce an intermediary 
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form between the central LCL and the two polar MCL and ADCL, the borderline disseminated 
cutaneous leishmaniasis (BDCL), which is distinguished by a partial inhibition of T-cell response [3, 4].  
Histological sections from biopsies obtained from lesions of a total of 30 patients with ADCL, 
BDCL and LCL caused by L. (L.) amazonensis (hyposensitivity poloDTH-) and LCL, LCM by L. (V.) 
braziliensis  (hyposensitivity poloDTH+) were submitted to immunohistochemical analysis. The 
epidemiological information is described in Table 1. By comparing the cell population according to 
the Leishmania species that caused American Cutaneous Leishmaniasis (ACL) (Figure 6), it was 
verified that there was a higher density of HDAC1-expressing cells (P<0.0001) in samples from 
patients with ACL L. amazonensis (hyposensitivity pole/ DTH-) when compared to patients with LCL 
L. braziliensis (hypersensitivity pole/ DTH+). The negative controls are shown in Supplementary 
Figure 5. These findings corroborate our in vitro data and highlight the role of the HDAC1 in human 
cutaneous infection caused by L. amazonensis. 
 
DISCUSSION 
While signaling pathways and transcriptional regulators act on a limited subset of genes, 
epigenetic regulators tend to control gene expression in a global manner, having a concomitant 
effect on cell functions [23]. Covalent post-translations modifications of histones are one of the 
mechanisms whereby cells modify the chromatin status and play a major role in eukaryotic gene 
regulation [24]. Epigenetic changes in the host cell during infection, known as patho-epigenetics, it is 
an emerging area of research for many aspects of infections disease with particular relevance in the 
regulation of intracellular infections. 
Several intracellular pathogens induce chromatin modifications and promote changes in the 
gene expression of the host (25). Studies have shown that some virus infections lead to modulation 
of HDACs, resulting in changes in gene expression profile favoring infection [26, 27, 28]. Other 
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groups have shown that epigenetic manipulations of the host cell are promoted by intracellular 
bacteria [29- 33]. There is a growing body of evidence suggesting that protozoan parasites such as 
Leishmania, Toxoplasma, and Theileria manipulate host cells via epigenetic modification of host 
gene expression [34].  
A balance between the ability of the immune response to activate Leishmania-infected 
macrophages and the ability of the parasite to resist cytotoxic mechanisms of macrophage activation 
determines parasite persistence within the macrophages. The parasite may adopt mechanisms to 
cope with oxidative stress [35, 36]. A hallmark of L. amazonensis infection is the downregulation of 
macrophage activation enabling parasite survival and replication [37- 39].  
In the present work, we demonstrated a sophisticated evolutive mechanism involving 
epigenetic modifications in iNOS promoter during the infection. We have showed that L. 
amazonensis induces the upregulation of HDAC1 and determines the silencing of iNOS promoter 
through p50-HDAC1 complex with a concomitant reduction in the levels of H3K9Ac. The importance 
of these events for the course of the infection was verified in HDAC1 knocked-down macrophages 
where an impaired growth of the intracellular parasites was observed.  In an attempt to test HDACs 
inhibitors, L. amazonensis infected macrophages were treated with Trichostatin A or MS-275, but no 
reproducible results were obtained, probably due to the difficulty to specifically inhibit HDAC1 (data 
not shown). 
High levels of NO, which is involved in the killing of parasite, have been observed in lesions 
of patients infected with L. tropica [40]. However, skin biopsies from patients infected with L. 
mexicana showed that the expression of iNOS was most prominent in lesions with small numbers of 
parasites whereas lesions with a high parasite burden contained considerably fewer iNOS-positive 
cells [41]. Corroborating these findings, we verified that NO levels were increased in L. amazonensis 
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HDAC1 knocked-down infected macrophages, which exhibited reduced parasite load compared to 
infected control cells. 
Clinical samples from patients infected with L. amazonensis 
DHT-
 clearly showed a 
strong expression of HDAC1 compared with the samples from patients infected with L. 
braziliensis
DHT+
. A hallmark feature of the immunological response in L. braziliensis 
infections is a strong Th1 type immune response to soluble Leishmania antigen (SLA), 
demonstrated by a positive DTH reaction to the Leishmania skin test, as well as lymphocyte 
proliferation and high levels of IFN-γ and TNF-α [42, 43].  On the other side, L. amazonensis 
infections present a suppressive Th1 type immune response, negative DTH reaction and high 
levels of IL-4 [3]. HDAC1 increased expression in lesions from patients infected with L. 
amazonensis correlates with its immunopathological response, due to negatively regulation of 
iNOS expression. Moreover, HDAC1 may have a wide role in the “silent” pro-inflammatory 
scenario during the infection. RNAseq assays are in progress to address this question, using 
L. amazonensis- infected HDAC1 knocked-down macrophages in an attempt to find new 
HDAC1 targets relevant for the infection.  
 The enhancement of HDAC1 levels appears to be an ingenious strategy employed by this 
intracellular parasite to reduce the host defense, by means of decreasing the gene expression of, 
probably, a repertoire of genes involved in the macrophage response to infections. A similar 
regulatory mechanism was demonstrated in Mycobacterium tuberculosis infection. It was verified 
the increase of HDAC1 expression with a reduction in the levels of histone H3-acetylation at IL-12B 
promoter in macrophages containing virulent M. tuberculosis [33]. Garcia-Garcia [29] showed that 
the intracellular bacteria, Anaplasma phagocytophilum, led to silencing of host defense gene 
expression. It was shown that HDAC1 expression, activity and binding to the defense gene 
promoters significantly increased during infection, which resulted in decreased histone H3 
acetylation in infected cells. Another work showed the upregulation of HDAC4 in L. donovani 
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infected macrophages, but the relevance for the gene expression regulation was not evaluated [38].  
In Pseudomonas aeruginosa infection, the bacteria-induced infection tolerance seems to be 
regulated via HDAC1. Therefore, it was verified a hypo-acetylation of lysine 1 of histone H3 at pro-
inflammatory cytokine promoter [44].  
The regulation of human HDAC1 promoter has been described in colon cancer cells where it 
is overexpressed. Two important binding sites for the transcription factor Sp1 at HDAC1 promoter 
have been reported. The one located -240 region seems to regulate HDAC1 promoter induction 
whereas the -40 site is related to the basal transcription activity [21]. Based on this, we investigated 
in our model whether Sp1 regulates HDAC1 promoter. Our data strongly suggests that Sp1 
contributes to the upregulation of HDAC1 expression in infected macrophages. This data is in 
agreement with the reported findings that L. amazonensis is able to induce the activation of Sp1. In 
fact, Yang [22] showed that in L. amazonensis induces ERK1/2 activation, which phosphorylates 
histone H3 at the IL-10 promoter favoring the binding of Sp1 to IL-10 promoter and leading to its 
activation. We also tested the role of AP1 in the context of HDAC1 induced activation. Our results 
showed that the inhibition of AP1 reduces the levels of increased HDAC1 levels during the infection. 
Since there are some discrepancies on the characterization of AP1 putative binding sites on the 
HDAC1 promoter, other experiments are in progress to address the actual binding to HDAC1 
promoter.  
In brief, we are proposing a model in which we demonstrate unique aspects of epigenetic 
changes in the host cell during L. amazonensis infection due to HDAC1 increased expression. This 
study can provide clues to understand the diversity of clinical manifestations in cutaneous 
leishmaniasis and may pave the way for novel therapeutic interventions.  
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MATERIALS AND METHODS 
Cell culture 
The human monocytic leukemia cell line THP-1 (ATCC: TIB202TM) was cultured in RPMI 
(Gibco) medium supplemented with 10% fetal bovine serum (Sigma),. These cells were differentiated 
to macrophages with 40ng/mL PMA (Sigma) for 72 h. Mouse macrophage leukemia cell line RAW 
264.7 (ATCC: TIB-71) and Human embryonic kidney cell line HEK-293FT (Life Technologies) were 
cultured in DMEM (Gibco) medium supplemented with 10% fetal bovine serum. HEK-293FT cells 
were maintained in medium containing 500g/mL geneticin. 
Parasites, culture conditions and infection 
L. (L) amazonensis (WHOM/R/75/Josefa) and L. (L) major strain LV39 (MRHO/ Sv/ 59/ P) were 
maintained in vitro in Schneider Insect Medium (Sigma) supplemented with 10% of fetal bovine 
serum.  The infection was carried out with stationary phase promastigotes at a parasite-to-cell ratio 
of 5:1 in triplicate. Differentiated THP1 or RAW cell lines were plated on glass coverslips and cultured 
overnight at 37°C. The cultures were washed and infected for 4 h at 37°C, followed by washing, 
fixation with methanol, and Giemsa staining. The number of intracellular parasites was determined 
by counting ≥100 cells/replicate under a light microscope. For the survival assays, the cells were 
infected for 4 h, washed, and further cultured for 48 h. The AP1 inhibitor, SR 11302, (iAP1) (CAS 
160162-42-5, Santa Cruz Biotechnology) was used as a pre-treatment (1.5M) for 30min . 
Quantitative Real Time PCR 
Total RNA of THP-1 differentiated cells was extracted with RNeasy® Plus (Quiagen) and 1g 
total RNA was reverse-transcribed into the first-strand cDNA with ImProm (Promega) and oligo(dT) 
12–18 primer, according to the manufacturer's instructions. The following pairs of primers were 
used to determinate human HDAC1 mRNA levels: 5' CAAGTACCACAGCGATGACTACATTAA-3' and 
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Reverse: 5'-GCTTGCTGTACTCCGACATGTT-3' GAPDH Forward 5’- TGCACCACCACCTGCTTAGC- 3´ and 
GAPDH Reverse 5’ GGCATGGACTGTGGTCATGAG- 3’ were used for normalization. Real time 
quantitative PCR (qPCR) was carried out via the Applied Biosystems 7500 detection system using 
Power SYBR Green PCR Master Mix (Applied Biosystems). All qPCR experiments were performed at 
least 3 times. All expression ratios were computed via the ΔΔCt method. 
Immunoblotting 
Differentiated THP-1 or RAW 264.7 cells were infected with L. amazonensis and total and nuclear 
protein extract were obtained.  For total extract the cell pellet was  ressuspended in  lysis  buffer  
(Tris-HCL pH 7,4 50 mM;  EDTA 0.1mM; NaF 50mM; - glycerophosphate 10mM; NaCl 150mM; 
Triton X-100 1%; glycerol 10%; sodium orthovanadate 1mM; protease inhibitor)  and incubated 
during 10min on ice. For the nuclear protein extraction, the cell pellet was ressupended in A buffer 
(HEPES pH 7.9 10mM; KCl 10mM; EDTA 0.1mM; EGTA 0.1mM; protease inhibitor) and incubated 
during 15min on ice. The samples were submitted to centrifugation (1810g) during 5min at 4ºC. The 
nuclear pellet was washed with A buffer, ressuspended in C buffer (HEPES pH 7.9 20mM; NaCl 0.4M; 
EDTA 1mM; EGTA 1mM; glycerol 20%; protease inhibitor ) and incubated on ice during 30min and 
centrifuged (12000g) for 10min. The nuclear proteins were collected in the supernatant. Both 
nuclear and total proteins were subjected to electrophoresis in 10% SDS-polyacrylamide gels. Blots 
were separately incubated with primary antibody against lamin A/C (Cell Signaling 2032), HDAC1 
(Santa Cruz Biotechnology, sc-6298), -actin (Sigma- Aldrich A2228), histone H3 (#9715, cell 
signaling) and tubulin (Santa Cruz Biotechnology, sc-12462).   
Chromatin immunoprecipitation assay - ChIP 
ChIP analysis was carried out according to the Simple ChIP Enzimatic Chromatin IP Kit 
protocol (Cell Signaling). RAW 264.7 cells or differentiated THP-1 cells were submitted to ChIP assay 
as described [19]. The chromatin was immunoprecipitated with of anti-p50 (Millipore – 06-886) anti-
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HDAC1 (sc-6298), anti-H3Ac (#9671S, cell signaling), anti-CBP/p300 (sc-369X), anti- histone H3 
(#9715, cell signaling) antibodies at 4°C under rotation for 16 h. The DNA isolated from 
immunoprecipitated material was ampliﬁed by real time PCR using SyberGreen for murine iNOS 
promoter: Foward 5`-ACACAGACTAGGAGTGTCCATCATGA-3` and Reverse: 5`- 
ACAAGACCCAAGCGTGAGAGGCCTCA- 3` and human iNOS promoter Forward: 5'-
GAGGGCTTTCCCAGAACCAAG-3' and Reverse: 5'-GGCTACTGACCCAGCAGTTC-3'. For human Sp1 
promoter (-240 site) the following primers were used: Forward: 5’-TCAGAAAGTTGGCCTCCGATC-
3’and Reverse: 5’-CTGGGCCTGTACCAAGGTCTG-3’. As a control, 1/50 of digested input chromatin 
was similarly processed and analyzed in the absence of immunoprecipitation. To calculate the input 
percentage of the samples, input was adjusted to 100% (IPadj = Ct avr(IP) − log2 50), followed by 
application of the formula 100 × 2*IPadj − Ct avr(IP)], where IPadj is adjusted input, and Ct avr(IP) is average Ct 
of input. 
Lentivirus transduction 
THP-1 cells knock-down for HDAC1 expression was obtained by lentivirus transduction 
described previously [45]. The human shRNA HDAC1 constructions (shRNA 1 - TRCN0000004816; 
shRNA 2 - TRCN0000195672; shRNA 3 - TRCN0000197176 and the non-target shRNA (SHC002) 
(Scrambled) from Broad Institute, USA were purchased from Sigma-Aldrich. After 6 days of 
transduction, THP-1 cells were selected with 1g/mL of puromycin for 12 days.  
Determination of nitrite 
Griess reaction was employed to analyze the nitrite (NO2
−) content as an indicator of NO 
production in supernatant cultures of THP1 cells. As a standard, the absorbance at 540nm was then 
measured following the incubation of supernatants the solution containing N-[naphthyl] 
ethylenediamine dihydrochloride (Need), sulfanilamide and phosphoric acid. 
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Luciferase reporter assay 
THP-1 cells were transfected with 0.5 g of luciferase reporter plasmid HDAC1-luc (S718920, 
Switch Gear) using NucleofectorTM Technology (Lonza, Basel, Switzerland). For normalization of the 
luciferase readout, the plasmid pRL-CMV (Promega) was used. The cells were lysed according to the 
Dual Luciferase System protocol (Promega), and analyzed using the GloMax®-Multi detection system 
(Promega Corp., Madison, WI, USA).  
HDAC activity 
Differentiated THP-1 cells were infected with L. amazonensis and nuclear extract proteins 
were obtained as described. The extract was submitted to HDAC activity colorometric assay kit from 
BioVision (#K331).  
 
Immunohistochemistry  
Thirty patients were diagnosed with ACL in the ambulatory section of the Prof. Dr. Ralph 
Lainson Leishmaniasis Laboratory of the Evandro Chagas Institute, Para State, Brazil based on 
clinical, epidemiological, parasitological and immunological features. Biopsies from patients were 
deparaffinized in xylene for 10 minutes and hydrated in descending series of alcohol. The epitope 
retrieval was performed in hot citrate bath (10 mm/pH 6.0) for 40 minutes. Then, endogenous 
peroxidase was blocked using a solution of hydrogen peroxide 3% and the slides were incubated in a 
humid chamber, overnight at 4°C, with goat polyclonal antibody raised against a peptide mapping at 
the C-terminus of HDAC1 human (1:50, C-19; SC 6298, Santa Cruz Biotechnology, Santa Cruz, CA, 
USA) diluted in PBS 1% BSA. For development of the reaction, the LSAB kit (Dako, Carpinteria, CA, 
USA) and diaminobenzidine (Sigma, St. Louis, MO, USA) in PBS containing 3% hydrogen peroxide 
were used. All reactions were performed with positive and negative controls. Negative controls were 
constituted by the use of normal goat serum (1;25,000, X0907, Agilent/Dako,Glostrup, Denmark) at 
the same protein concentration as the primary antibody and omission of the primary antibody. At 
least ten sequential images of each histological section were acquired using a system composed of 
microscope AxioShop 2 Plus, color video camera connected to computer with AxionVision 4.2 
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software (Carl Zeiss, San Diego, CA, USA). Immunolabeled cells were quantified by counting in the 
software and cell densities (cells/mm2) were calculated.  
Cell Viability Assay 
The MTT reagent 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (M2128) 
(Sigma) was used according [46]. 
Statistical analyses 
Statistical analyses were performed using the Prism program (GraphPad, San Diego, CA, 
USA) and Student’s t test for independent samples or One-way ANOVA, with the Bonferroni post hoc 
test. 
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FIGURE LEGENDS 
FIGURE 1.  HDAC1-p50 complex downregulates iNOS promoter during L. amazonensis infection. 
RAW 264.7 cells were infected for 5 h with L. amazonensis or L. major as indicated; and the 
chromatin immunoprecipitation assay was performed with the antibodies: anti-HDAC1 (A and B) and 
anti-H3K9Ac (D). In Re-ChIP assay (C) the anti-HDAC1 antibody in the first reaction and the collected 
complex was precipitated with anti-p50 for the second immunoprecipitation. The 
immunoprecipitated chromatin was amplified by real time PCR using specific primers to κB-binding 
sites in the iNOS gene promoter. The H3K9Ac results were normalized with H3 immunoprecipitation. 
Experiments were performed 3 independent times in triplicates. Graphs are representative of 1 
experiment and indicate means ± SD of experiments performed in triplicate. Statistical analyses were 
performed using Unpaired t- test.  *** p =0.0003; ** p =0.0079; * p = 0.0265. 
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FIGURE 2. HDAC1 expression is increased in L. amazonensis-infected macrophages. THP-1 cells were 
differentiated and infected with promastigotes of L. amazonensis or L. major as indicated. The 
nuclear (A) and total (B and D) protein extracts were obtained and subjected to Western blot using 
the anti-HDAC1. Anti- lamin A/C and anti-tubulin were used as endogenous control. C) Histone 
deacetylase activity was carried out with nuclear extracts from differentiated THP-1 cells not 
infected (control) or infected with L. amazonensis as indicated. Relative levels of HDAC1, were 
calculated by densitometry and are indicated at bottom. Experiments were performed 3 
independent times in triplicates. Graphs are representative of 1 experiment and indicate means ± SD 
of experiments performed in triplicate. Statistical analyses were performed using One-Way ANOVA.  
** p <0.0001. 
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FIGURE 3.  L. amazonensis increases HDAC1 promoter activity. THP-1 cells were differentiated and 
infected with promastigotes. A) The total RNA was extracted at 4h of infection and cDNA synthesis 
were performed. The samples were subjected to qPCR as previously described. (B) Differentiated 
THP1 cells were transiently transfected with the reporter plasmid pHDAC1-LUC and were infected 
for 24 h. Non-infected cells were used as negative controls for basal luciferase activity. (C) 
Differentiated THP1 cells were infected for 5 h with L. amazonensis; and the chromatin 
immunoprecipitation assay was performed with the antibodies anti-Sp1. The immunoprecipitated 
chromatin was amplified by real time PCR using specific primers to Sp1-binding sites located at the 
HDAC1 gene promoter. Differentiated THP1 cells were infected with L. amazonensis for 4 h or pre-
treated with 1.5M of AP1 inhibitor (iAP1) during 30min or DMSO. The total RNA (D) was extracted 
and cDNA synthesis were performed. The samples were subjected to qPCR to verify HDAC1 
transcript levels and -actin was used as an endogenous control. The total protein extracts (E) were 
obtained and subjected to Western blot using the anti-HDAC1 and anti- -actin as endogenous 
control. Relative levels of HDAC1, calculated by densitometry, are indicated at bottom. Experiments 
were performed 3 independent times in triplicates. Experiments were performed 3 independent 
times in triplicates. Graphs are representative of 1 experiment and indicate means ± SD of 
experiments performed in triplicate. Statistical analyses were performed using Unpaired t- test.  * p 
= 0.0039; ** p = 0.0019; *** p = 0.0008. Graphs are representative of 1 experiment and indicate 
means ± SD of experiments performed in triplicate. Statistical analyses were performed using 
Unpaired t- test.  * p = 0.0039; ** p = 0.0019; *** p = 0.0008. The One-Way ANOVA analyses was 
used in D; ***  p =0.0004 
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FIGURE 4. HDAC 1 knocked-down expression impairs L. amazonensis growth in infected 
macrophage. A) Western blot of total protein extract obtained form differentiated THP-1 stably 
knocked-down for HDAC 1 expression. Monocytic THP-1 were not transduced or transduced with 
lentivirus carrying the construction: shScr (Scrambled), shHDAC 1 (1), shHDAC 1(2) and shHDAC 1 (3). 
Differentiated THP-1 cells knocked-down for HDAC 1 (3) were infected with L. amazonensis 
promastigotes. At 48h post-infection, the percentual of infected macrophage (B) and the number of 
parasites/ 100 cells (C) were evaluated. D) Differentiated THP-1 cells shScr or shHDAC 1 were 
infected with L. amazonensis and after 48h pos-infection the nitric oxide was measured in the 
culture cell supernatant as described in the Experimental Procedures. Experiments were performed 
3 independent times in triplicates. Graphs are representative of 1 experiment and indicate means ± 
SD of experiments performed in triplicate. Statistical analyses were performed using One-Way 
ANOVA.  ** p <0.0014; * p <0.0046. 
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FIGURE 5. HDAC1 expression is important to determine the occupancy of CBP-p300 and the levels of 
H3K9Ac in iNOS promoter during L. amazonensis infection. Differentiated THP-1 cells shScr or 
shHDAC 1 were infected with L. amazonensis. At 5h of infection, the chromatin immunoprecipitation 
assay was performed with the antibodies: CBP-p300 (A) and anti-H3K9Ac (B). The 
immunoprecipitated chromatin was amplified by real time PCR using specific primers to κB-binding 
sites in the iNOS gene promoter. The H3K9Ac results were normalized with H3 immunoprecipitation. 
Experiments were performed 3 independent times in triplicates. Graphs are representative of 1 
experiment and indicate means ± SD of experiments performed in triplicate. Statistical analyses were 
performed using One-Way ANOVA.  *** p <0.0001. 
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FIGURE 6. Skin lesions from patients with ACL caused by L. (L.) amazonensisDTH- exhibit higher 
expression of HDAC1 than L.(V.) braziliensisDTH+ in immunohistochemistry analysis. Graphic analysis 
of immunoreactive cells density(mean ± SEM) for HDAC1.  (A and B) Histological sections from 
biopsies obtained from lesions of patients with ADCL, BDCL and LCL caused by L. (L.) amazonensis 
(hyposensitivity poloDTH-) and LCL, LCM by L.(V.)braziliensis (hyposensitivitypoloDTH+) were submitted 
to immunohistochemical reaction with antibodies against HDAC1, as described previously. 
Immunoperoxidase staining of skin lesion with nuclear localization (400x) and positive cell density 
were obtained. Images are representative of sections from 16 patients   
 with ACL L.(L.) amazonensis (DTH-) and 14 with ACL L.(V.) braziliensis  (DTH+). Statistically significant 
differences were determined using a two-tail parametric t- test. n = 30. *P< 0.0001.DTH= delayed-
type hypersensitivity. 
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FIGURE 7. Proposed model for HDAC1 in L. amazonensis infection. As previously described, L. 
amazonensis infection induces PI3K/Akt pathway (1) to promote the formation of p50/ p50 NF-B 
homodimers (2). In this work, we demonstrated that L. amazonensis through Sp1 induction (3) 
increases HDAC1 expression (4). We also verified that the infection induces the formation of HDAC1-
p50/p50 complex, which determines iNOS promoter repression associated with the low levels o 
H3K9Ac (5) and the reduction of NO production (6) favoring the replication the parasites (7). On the 
other hand, the reduction of HDAC1 expression using shRNA (8), revert the iNOS inhibition and 
increase the H3K9Ac levels at this promoter (9) leading to NO production (10) and culminates in a 
negative effect on intracellular Leishmania proliferation (11). 
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Graphic Abstract 
Leishmania amazonensis infection induces NF-B p50/p50 and increases the nuclear levels of HDAC1 
in macrophages. In the nucleus, p50/50 binds to nk promoter sequences and recruits HDAC1, 
forming a repression complex leading to H3K9 deacetylation and consequent iNOS promoter 
silencing. The absence of Nitric Oxide production favors the amastigote growth.  
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Table 1: Clinical and epidemiological characteristics of patients with American cutaneous 
leishmaniasis caused by L. (L.) amazonensis (hyposensitivity polo DTH-) and L. (V.) braziliensis 
(hypersensitivity polo DTH+) 
Hyposens
itivity 
polo 
Pati
ent 
Clini
cal 
for
m 
Age 
(ye
ar) 
S
e
x 
State, 
Countr
y 
Time of 
disease 
(month/
year) 
Lesion 
type 
Num
ber of 
lesion 
Parasite 
demonstr
ation 
DTH 
La(LCL-) 1 LCL 21 M Pará, 
Brazil 
6 m ulcered 1 positive negati
ve 
La(LCL-) 2 LCL 10 M Pará, 
Brazil 
2 m ulcered 1 positive negati
ve 
La(LCL-) 3 LCL 41 M Pará, 
Brazil 
2 m ulcered 4 positive negati
ve 
La(LCL-) 4 LCL 28 M Pará, 
Brazil 
9 m ulcered 1 not 
performe
d 
positiv
e 
La(LCL-) 5 LCL 36 M Pará, 
Brazil 
6 m ulcered 1 positive positiv
e 
La(LCL-) 6 LCL 41 M Pará, 
Brazil 
2 m ulcered 4 positive negati
ve 
La(LCL-) 7 LCL 47 M Pará, 
Brazil 
2 m ulcered 1 positive negati
ve 
La(LCL-) 8 LCL 29 F Pará, 
Brazil 
5 m ulcered 1 positive negati
ve 
La(LCL-) 9 LCL 34 M Pará, 
Brazil 
3 m ulcered 2 positive negati
ve 
La(BDCL-) 10 BDC
L 
57 M Pará, 
Brazil 
1 y infiltrated 
and 
nodular 
2 positive negati
ve 
La(BDCL-) 11 BDC
L 
33 M Pará, 
Brazil 
2 y infiltrated 
and 
nodular 
count
less 
positive negati
ve 
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La (BDCL-) 12 BDC
L 
49 M Pará, 
Brazil 
5m ulcered 3 positive positiv
e 
La (ADCL-) 13 ADC
L 
42 M Pará, 
Brazil 
35 y nodular 
and 
vegetativ
e 
count
less 
positive negati
ve 
La (ADCL-) 14 ADC
L 
31 M Pará, 
Brazil 
28 y nodular 
and 
vegetativ
e 
count
less 
positive negati
ve 
La (ADCL-) 15 ADC
L 
59 M Amapá
, Brazil 
20 y Acneform
, 
infiltrated 
and 
nodular 
count
less 
positive negati
ve 
La(ADCL-) 16 ADC
L 
9 M Pará, 
Brazil 
1 y vegetativ
e 
count
less 
positive negati
ve 
La(ADCL-) 17 ADC
L 
45 F Maran
hão, 
Brazil 
20y nodular 
and 
vegetativ
e 
count
less 
positive negati
ve 
La(ADCL-) 18 ADC
L 
24 M Maran
hão, 
Brazil 
19y nodular 
and 
vegetativ
e 
count
less 
positive negati
ve 
Hypersensitivity polo 
Lb(LCL+) 19 LCL 18 M Pará, 
Brazil 
3m ulcered 3 positive positiv
e 
Lb(LCL+) 20 LCL 40 M Pará, 
Brazil 
17m ulcered 2 negative positiv
e 
Lb(LCL+) 21 LCL 20 M Pará, 
Brazil 
2 m ulcered 1 positive not 
perfor
med 
Lb(LCL+) 22 LCL 63 F Pará, 
Brazil 
6 m ulcered 1 positive positiv
e 
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Lb (LCL+) 23 LCL 30 M Pará, 
Brazil 
3 m ulcered 1 positive not 
perfor
med 
Lb (LCL+) 24 LCL 31 M Pará, 
Brazil 
2 m ulcered 1 negative positiv
e 
Lb (LCL+) 25 LCL 31 M  Pará, 
Brazil 
5 m ulcered 2 negative positiv
e 
Lb (LCL+) 26 LCL 46 M Pará, 
Brazil 
3 m ulcered 1 positive positiv
e 
Lb (BDCL+) 27 BDC
L 
48 M Pará, 
Brazil 
29 m papulo-
ulcerative 
6 positive positiv
e 
Lb (BDCL+) 28 BDC
L 
61 M Pará, 
Brazil 
3 m papulo-
ulcerative 
count
less 
positive not 
perfor
med 
Lb (LCM+) 29 MCL 41 M Pará, 
Brazil 
2 y infiltrated 
granulom
atous 
1 positive positiv
e 
Lb (LCM+) 30 MCL 27 M Pará, 
Brazil 
1 y infiltrated 
granulom
atous 
2 positive positiv
e 
 
 
 
